| All the news about G1 THERAPEUTICS, INC. |
|
|
|
|
|
| ANALYST RECOMMENDATIONS FOR G1 THERAPEUTICS, INC. |
|
|
|
|
|
|
| CA 2022 |
51.3 m
–
49.9 m
|
| 2022 net result |
– 152 m
–
– 148 m
|
| net debt 2022 |
–
–
–
|
| per 2022 |
-1.81 times |
| Return 2022 |
– |
|
| capitalization |
323 m
323 m
314 m
|
| Cappy. / CA 2022 |
6.30 times |
| Cappy. / CA 2023 |
4.76 times |
| Number of Employees |
148 |
| floating |
77.1% |
|
| Scheme G1 THERAPEUTICS, INC. |
|
Difficult :
a period:
|
|
|
|
Trends Technical Analysis G1 THERAPEUTICS, INC.
|
Short term |
middle limit |
Long term |
| trends |
bearish |
neutral |
neutral |
The evolution of the income statement
|
|
| Average recommendation |
plural |
| number of analysts |
8 |
| The last closing price |
$6.38 |
| Average target price |
$32.86 |
| Deviation/average of target |
415% |
|
